“The global enteral feeding formulas market is expected to grow at a CAGR of 7.6% during the forecast period of 2015-2020 and is estimated to be worth USD 5.95 billion by 2020. The market is mainly driven by factors such as rising incidences of chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. However, factors such as complications associated with enteral nutrition, patient safety risks, and the risk of feeding and medication errors are some restraints for the growth of the enteral feeding formulas market.
In this report, the global enteral feeding formulas market is segmented by product, stage, application, end user, and region.
On the basis of products, the market is classified into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric and monomeric formulas. The disease-specific formulas included in this report are subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the enteral feeding formulas market is segmented into adults and pediatrics. On the basis of applications, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. By end user, the enteral feeding formulas market is segmented into hospitals and long-term care facilities. Long-term care facilities are further segmented into homecare agencies & hospices and nursing homes and assisted living facilities.
Geographically, North America accounted for the largest share of the global enteral feeding formulas market in 2015, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The Asia-Pacific region is expected to record the highest market growth during the forecast period due to the presence of a large patient pool for chronic diseases and disorders, high incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and growing population in emerging APAC countries.
In 2015, Abbott Laboratories (U.S.), Nestlรฉ S.A. (Switzerland), Danone S.A. (France), and Fresenius Kabi AG (Germany) were the leading players in the enteral feeding formulas market.
Reasons to Buy the Report
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.
This report provides insights on the following pointers:
โข Market Penetration: Comprehensive information on product portfolios offered by the top players in the enteral feeding formulas market. The report analyzes the enteral feeding formulas market by stage, product, application, and end user across all regions
โข Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and new product launches in the enteral feeding formulas market
โข Market Development: Comprehensive information of the lucrative emerging markets by stage, product, application, end user, and region
โข Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the global enteral feeding formulas market
โข Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of the leading players in the global enteral feeding formulas market